Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Florida Cancer Specialists, Sarasota, Florida SCRI Oncology Partners, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas NEXT Oncology, San Antonio, Texas NEXT Virginia, Fairfax, Virginia